Scientific Bibliography

A Scientific Bibliography with topics and abstracts related to nanotechnology is featured on the NCI Alliance for Nanotechnology in Cancer website.

Select NCL publications are listed here:

Sterilization of silver nanoparticles using standard gamma irradiation procedure affects particle integrity and biocompatibility.
Zheng, J.; Clogston, J. D.; Patri, A. K.; Dobrovolskaia, M. A.; McNeil, S. E.
Journal of Nanomedicine and Nanotechnology, November 2011 [Epub ahead of print].
DOI: 10.4172/2157-7439.S5-001

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
Dobrovolskaia, M. A.; Patri, A. K., Simak, J., Hall, J. B., Semberova, J.; De Paoli Lacerda, S. H.; McNeil, S. E.
Molecular Pharmaceutics 2011 Nov 10. [Epub ahead of print]
PMID: 22026635.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
Nanomedicine (Lond). 2011 Sep 30. [Epub ahead of print]
PMID: 21957862.

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.
Afonin ,K. A.; Grabow, W. W.; Walker, F. M.; Bindewald, E.; Dobrovolskaia, M. A.; Shapiro, B. A.; Jaeger, L.
Nature Protocols, 2011, 6(12), 2022-2034.
PMID: 22134126.

Preclinical efficacy and toxicity testing of engineered nanomaterials in Nanomedicine – Basic and Clinical Applications in Diagnostics and Therapy.
Grossman, J. H.; McNeil, S. E.
Else Kroner-Fresenius Symposia, Karger Press; 2011, vol. 2, p71-79, Christoph Alexiou, editor. 
ISBN: 978-3-8055-9818-7.

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.
Franca, A.; Aggarwal, P.; Barsov, E.; Kozlov, S.; Dobrovolskaia, M. A.; Gonzalez-Fernandez, A.
Nanomedicine (Lond.), 2011, 6(7), 1175-1188.
PMID: 21675859.

Newkome-type dendron stabilized gold nanoparticles: Synthesis, reactivity, and stability.
Cho, T. J.; Zangmeister, R. A.; Maccuspie, R. I.; Patri, A. K.; Hackley, V. A.
Chemistry of Materials, 2011, 23(10), 2665-2676.
PMID: 21686078.

Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment.
Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A., Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A.; Colvin, V. L.; Kreyling, W.; Krug, H. F.; Lewicka, Z. A.; McNeil, S. E.; Nel, A.; Patri, A. K.; Wick, P.; Wiesner, M.; Xia, T.; Oberdorster, G.; Dawson, K. A.
Journal of Nanoparticle Research, 2011, 13(7), 2675-2687.

Characterization of nanoparticles intended for drug delivery.
Methods in Molecular Biology: Humana Press; 2011, Scott E. McNeil, editor.
ISBN: 978-1-60327-197-4

Fullerenol Cytotoxicity in Kidney Cells is Associated with Cytoskeleton Disruption, Autophagy Induction, and Mitochondrial Dysfunction
Johnson-Lyles, D. N.; Peifley, K.; Lockett, S.; Neun, B. W.; Hansen, M.; Clogston, J.; Stern, S. T.; McNeil, S. E.
Toxicology and Applied Pharmacology, 2010, 248(3), 249-258.
PMID: 20713077

Translational considerations for cancer nanomedicine.
Stern, S. T.; Hall, J. B.; Yu, L. L.; Wood, L. J.; Paciotti, G. F.; Tamarkin, L.; Long, S. E.; McNeil, S. E.
Journal of Controlled Release. 2010, 146(2), 164-174.
PMID: 20385183

Biological Assessment of Triazine Dendrimers as Candidate Platforms for Nanomedicine: Toxicological Profiles, Solution Behavior, Biodistribution, and Drug Release and Efficacy in a PEGylated, Paclitaxel Construct.
Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J.; Patri, A.; Sun, X.; Simanek, E. E.
Molecular Pharmaceutics, 2010, 7(4), 993-1006.
PMID: 20481608

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
Ahn, R.; Chen, F.; Stern, S. T.; Clogston, J. D.; Patri, A. K.; Raja, M. R.; Swindell, E. P.; Parimi, V.; Cryns, V. L.; O’Halloran, T.
Clinical Cancer Research, 2010, 16(14), 3607-3617.
PMID: 20519360

Ambiguities in applying traditional Limulus Amoebocyte Lysate tests to quantify endotoxin in nanoparticle formulations.
Dobrovolskaia, M. A.; Neun, B. W.; Clogston, J. D.; Ding, H.; Ljubimova, J.;
McNeil, S. E.
Nanomedicine (Lond.), 2010, 5(4), 555-562.
PMID: 20528451

Lack of significant dermal penetration of titanium dioxide (TiO₂) from sunscreen formulations containing nano- and sub-micron-size TiO₂ particles.
Sadrieh, N.; Wokovich, A. M.; Gopee, N. V.; Zheng, J.; Haines, D.; Parmiter, D.; Siitonen, P. H.; Cozart, C. R.; Patri, A.; McNeil, S. E.; Howard, P. C.; Doub, W. H.; Buhse, L. F.
Toxicological Sciences, 2010, 115(1), 156-166.
PMID: 20156837

Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of (198)AuNP-GA nanoconstruct in prostate tumor-bearing mice.
Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V.
Nanomedicine:Nanotechnology, Biology, and Medicine, 2010, 6(2), 201-209. 
PMID: 19914401

Minireview: Nanoparticles and the immune system.
Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
Endocrinology. 2010, 151(2), 458-465. 
PMID: 20016026

Nanomaterial standards for efficacy and toxicity assessment.
Adiseshaiah, P.; Hall, J. B.; McNeil, S. E.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2010, 2(1), 99-112.  PMID: 20049834

Quantitative characterization of quantum dot-labeled lambda phage for Escherichia coli detection.
Yim, P. B.; Clarke, M. L.; McKinstry, M.; De Paoli Lacerda, S. H.; Pease, L. F.; Dobrovolskaia, M. A.; Kang, H.; Read, T. D.; Sozhamannan, S.; Hwang, J.
Biotechnology and Bioengineering. 2009, 104(6), 1059-1067. 
PMID: 19634184

Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice.
Patri, A.; Umbreit, T.; Zheng, J.; Nagashima, K.; Goering, P.; Francke-Carroll, S.; Gordon, E.; Weaver, J.; Miller, T.; Sadrieh, N.; McNeil, S. E.; Stratmeyer, M.
Journal of Applied Toxicology. 2009, 29(8), 662-672. 
PMID: 19626582

Immunological properties of engineered nanomaterials.
Dobrovolskaia, M.; McNeil, S. E.
Nanoscience and Technology: A Collection of Reviews from Nature Journals: World Scientific Publishing Company 2009, Peter Rodgers, editor. 
ISBN: 978-981-4282-68-0

Evaluation of nanoparticle immunotoxicity.
Dobrovolskaia, M. A.; Germolec, D. R.; Weaver, J. L.
Nature Nanotechnology. 2009, 4(7), 411-414. 
PMID: 19581891

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
Nanomedicine: Nanotechnology, Medicine, and Biology. 2009, 5(2), 106-117. 
PMID: 19071065

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E.
Advanced Drug Delivery Reviews. 2009, 61(6), 428-437. 
PMID: 19376175

Nanoparticle therapeutics: a personal perspective.
McNeil, S. E.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2009, 1(3), 264-271.  PMID: 20049796

In Review: Nanomaterial Safety.
McNeil, S. E.
Bulletin of the Atomic Scientists. 2009, 65(1), 56-61.

HER2-Specific affibody-conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents.
Puri, A.; Kramer-Marek, G.; Campbell-Massa, R.; Yavlovich, A.; Tele, S. C.; Lee, S.-B.; Clogston, J. D.; Patri, A. K.; Blumenthal, R.; Capala, J.
Journal of Liposome Research. 2008, 18(4), 293-307. 
PMID: 18937120

Detoxification of gold nanorods by treatment with polystyrenesulfonate.
Leonov, A. P.; Zheng, J. W.; Clogston, J. D.; Stern, S. T.; Patri, A. K.; Wei, A.
ACS Nano. 2008, 2(12), 2481-2488. 
PMID: 19206282

Role for nanomaterial-autophagy interaction in neurodegenerative disease.
Stern, S. T.; Johnson, D. N.
Autophagy. 2008, 4(8), 1097-1100. 
PMID: 18927490

Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials?
Stern, S. T.; Zolnik, B. S.; McLeland, C. B.; Clogston, J.; Zheng, J.; McNeil, S. E.
Toxicological Sciences. 2008, 106(1), 140-152. 
PMID: 18632727

Method for analysis of nanoparticle hemolytic properties in vitro.
Dobrovolskaia, M. A.; Clogston, J. D.; Neun, B. W.; Hall, J. B.; Patri, A. K.; McNeil, S. E.
Nano Letters. 2008, 8(8), 2180-2187. 
PMID: 18605701

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.
Zolnik, B. S.; Stern, S. T.; Kaiser, J. M.; Heakal, Y.; Clogston, J. D.; Kester, M.; McNeil, S. E.
Drug Metabolism and Disposition. 2008, 36(8), 1709-1715. 
PMID: 18490436

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
Molecular Pharmaceutics. 2008, 5(4), 487-495. 
PMID: 18510338

Biodistribution of nanomedicines.
Simanek, E.; Patri, A.
Molecular Pharmaceutics. 2008, 5(4), 473. 
PMID: 18672948

Adverse effects of fulerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.
Gelderman, M. P.; Simakova, O.; Clogston, J.; Patri, A.; Siddiqui, S. F.; Vostal, A. C.; Simak, J.
International Journal of  Nanomedicine. 2008, 3(1), 59-68. 
PMID: 18488416

Nanotechnology safety concerns revisited.
Stern, S. T.; McNeil, S. E.
Toxicological Sciences. 2008, 101(1), 4-21. 
PMID: 17602205

Characterization of nanoparticles for therapeutics.
Hall, J. B.; Dobrovolskaia, M. A.; Patri, A. K.; McNeil, S. E.
Nanomedicine. 2007, 2(6), 789-803. 
PMID: 18095846

Immunological properties of engineered nanomaterials.
Dobrovolskaia, M. A.; McNeil, S. E.
Nature Nanotechnology. 2007, 2(8), 469-478. 
PMID: 18654343

Medical opportunities of nanotechnology.
McNeil, S. E.
ISO Focus. April 2007, Nanotechnologies issue, p. 16-18.

Analysis of fullerene-based nanomaterial in serum matrix by CE.
Chan, K. C.; Patri, A. K.; Veenstra, T. D.; McNeil, S. E.; Issaq, H. J.
Electrophoresis. 2007, 28(10), 1518-1524. 
PMID: 17447247

Nanocrystal-based biomimetic system for quantitative flow cytometry.
Yim, P.; Dobrovolskaia, M.; Kang, H.; Clarke, M.; Patri, A.; Hwang, J.
Advanced Biomedical and Clinical Diagnostic Systems V, Proc of SPIE, Volume 6430, 2007; San Jose, CA: SPIE; 2007. p. 64301T1-64301T9, Vo-Dinh, T.; Grundfest, W. S.; Benaron, D. A.; Cohn, G. E.; Raghavachari, R., editors.
ISBN: 9780819465436

Preclinical characterization of engineered nanoparticles intended for cancer therapeutics.
Patri, A.; Dobrovolskaia, M.; Stern, S. T.; McNeil, S. E.
Nanotechnology for Cancer Therapy. New York: CRC Press; 2006. p. 105-138, Mansoor Amiji, editor.
ISBN: 978-0849371943

Nanotechnology for the biologist.
McNeil, S. E.
Journal of Leukocyte Biology. 2005, 78(3), 585-594. 
PMID: 15923216